Welcome to the healthier, happier world of 2030. Heart attacks and strokes are down 20%. A drop in food consumption has left ...

Wegovy and similar weight-loss medications are becoming widely prescribed for teenagers with obesity, but little is known ...

The Denmark-based drug maker Zealand Pharma said Tuesday that its experimental weight-loss drug could help patients lose ...

When Novo Nordisk reports earnings Wednesday morning, investors will be seeking reassurance that they haven’t overestimated ...

An injection pen of Zepbound, Eli Lilly’s weight-loss drug, is displayed in New York City, December 11, 2023. [Photo: Brendan ...

Viking Therapeutics shares climbed 9% on Monday after the drug developer's oral obesity treatment helped reduce body weight ...

As the popularity of GLP-1 meds like Wegovy and Zepbound grows, fewer Americans are turning to weight-loss surgeries to trim ...

Eli Lilly, the maker of the popular weight loss drug Zepbound, revealed a "shocking first miss" during its most recent ...

“Drugs approved for weight management should only be used by those tackling obesity, where diet and exercise has been tried ...

A new study suggests that weekly self-injections of the weight loss drug semaglutide could reduce knee pain from moderate osteoarthritis by nearly 50%.

Between 2022 and 2023, prescriptions for GLP-1 drugs soared 132.6% while bariatric surgery rates fell 25.6%, according to a new study from researchers at Boston-based Harvard Medical School and ...

Influencers have been offered tens of thousands of dollars to promote Ozempic and other drugs used for weight loss online. Several social media influencers confirmed to The Cut that ...